Alvir JM - Search Results

1

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA. Robinson D, et al. Among authors: alvir jm. Arch Gen Psychiatry. 1999 Mar;56(3):241-7. doi: 10.1001/archpsyc.56.3.241. Arch Gen Psychiatry. 1999. PMID: 10078501

2

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, Robinson DG, Alvir J, Lieberman J, Kane J, Bilder R. Gunduz H, et al. Biol Psychiatry. 2002 May 15;51(10):801-8. doi: 10.1016/s0006-3223(01)01345-2. Biol Psychiatry. 2002. PMID: 12007454

3

Mood responses of remitted schizophrenics to methylphenidate infusion.

Robinson D, Mayerhoff D, Alvir J, Cooper T, Lieberman J. Robinson D, et al. Psychopharmacology (Berl). 1991;105(2):247-52. doi: 10.1007/BF02244317. Psychopharmacology (Berl). 1991. PMID: 1796130 Clinical Trial.

4

Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.

Lieberman JA, Alvir J, Mukherjee S, Kane JM. Lieberman JA, et al. Among authors: alvir j. Arch Gen Psychiatry. 1989 Oct;46(10):908-13. doi: 10.1001/archpsyc.1989.01810100050009. Arch Gen Psychiatry. 1989. PMID: 2572205 Clinical Trial.

5

Prediction of relapse in schizophrenia.

Lieberman JA, Kane JM, Sarantakos S, Gadaleta D, Woerner M, Alvir J, Ramos-Lorenzi J. Lieberman JA, et al. Among authors: alvir j. Arch Gen Psychiatry. 1987 Jul;44(7):597-603. doi: 10.1001/archpsyc.1987.01800190013002. Arch Gen Psychiatry. 1987. PMID: 2886110 Clinical Trial.

6

Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.

Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM. Lieberman JA, et al. Among authors: alvir j. Neuropsychopharmacology. 1994 Oct;11(2):107-18. doi: 10.1038/npp.1994.40. Neuropsychopharmacology. 1994. PMID: 7840862 Clinical Trial.

7

Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.

Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T. Koreen AR, et al. Arch Gen Psychiatry. 1994 Feb;51(2):132-8. doi: 10.1001/archpsyc.1994.03950020056006. Arch Gen Psychiatry. 1994. PMID: 7905259

8

Time course and biologic correlates of treatment response in first-episode schizophrenia.

Lieberman J, Jody D, Geisler S, Alvir J, Loebel A, Szymanski S, Woerner M, Borenstein M. Lieberman J, et al. Arch Gen Psychiatry. 1993 May;50(5):369-76. doi: 10.1001/archpsyc.1993.01820170047006. Arch Gen Psychiatry. 1993. PMID: 8098203

9

Depression in first-episode schizophrenia.

Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Koreen AR, et al. Am J Psychiatry. 1993 Nov;150(11):1643-8. doi: 10.1176/ajp.150.11.1643. Am J Psychiatry. 1993. PMID: 8105706

10

Relation of plasma fluphenazine levels to treatment response and extrapyramidal side effects in first-episode schizophrenic patients.

Koreen AR, Lieberman J, Alvir J, Chakos M, Loebel A, Cooper T, Kane J. Koreen AR, et al. Am J Psychiatry. 1994 Jan;151(1):35-9. doi: 10.1176/ajp.151.1.35. Am J Psychiatry. 1994. PMID: 8267132 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters